U.S. Markets open in 7 hrs 32 mins

HCA Healthcare, Inc. (HCA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
155.06+5.66 (+3.79%)
At close: 4:00PM EST
Sign in to post a message.
  • C
    CID1000
    Dividend again in November?
  • S
    Stocktargetadvisor
    $HCA
    Maintains Raymond James Financial Outperform USD 140 » USD 150
    Target Raised by Credit Suisse Outperform USD 158 » USD 164
    Maintains Mizuho Securities Buy USD 145 » USD 150
  • Y
    Yahoo Finance Insights
    HCA Healthcare reached an all time high at 154.26
  • B
    Bunny
    Why ANTM has its sales growing, and free cash flow doubling while HCA not growing as fast?
  • Y
    Yahoo Finance Insights
    HCA Healthcare is down 5.81% to 124.57
  • D
    Darrell
    Too much debt
    Bearish
  • Y
    Yahoo Finance Insights
    HCA Healthcare is up 5.46% to 139.00
  • Y
    Yahoo Finance Insights
    HCA Healthcare is up 5.17% to 130.35
  • b
    ben
    What's going on??? Hit $119 and change
    Bullish
  • Y
    Yahoo Finance Insights
    HCA Healthcare is up 6.64% to 147.70
  • T
    Tommy
    Florida just allowed Elective procedures to go forward as of Monday May 4. Bed utilization is way down and there is a pretty good backlog of patients waiting for surgeries.
    Bullish
  • c
    chip
    Based on the First Care Act, each hospital was to receive approximately 100,000 per bed. HCA has almost 50000 beds. That means they could receive 5 billion dollars if they indeed divid the money according to the original concept. Saw today that the first 30 billion was released to the hospitals in accordance with the amount of medicare funds received (not sure of the time period)
  • R
    Rich
    Thanks for the thumbs down for the one individual who did this. Could this go back to $58? Sure, it could, however, I believe a vaccine will be announced in the next 6-8 weeks, and if that’s the case, people will buy this back to $100+ as people (the market) buy 6-9 months ahead. Vaccine would be in production by Feb/March of next year and so the stock would start reflecting that upon announcement with a huge bounce followed by a rise to over $100 by sometime in June.
  • T
    Tommy
    Now is the time to get those elective surgeries done, before the resurgence of the virus. This quarter should be OK, and maybe Q3 too. Q4 not so much.
    Bullish
  • M
    MemphisBBQ
    What is the short term future of HCA?
  • T
    Tommy
    I'm sorry, but what does near capacity with Covid-19 patients mean to you? I thought this was a bad investment when daily cases in Florida were 1-2K, and now we are in the 10-15K range? This price is not sustainable nor is their business model under this strain. SELL!
    Bearish
  • R
    RICHARD
    What a jump today after hours to >9%. Anyone know why?
  • Y
    Yahoo Finance Insights
    HCA Healthcare is up 6.01% to 139.75
  • j
    jim
    Nice jump up in premarket
    Bullish
  • D
    David
    https://www.twst.com/news/hospital-hospital-facilities-america-research-team-member-matt-larew-tells-invest/
    I think HCA (NYSE:$HCA) appears likely to continue to look for consolidation opportunities. The hospital sector in general is much more consolidated, and that’s largely in the hands of many nonprofits.

    But in the last year, we’ve seen a number of fairly large-scale mergers among some fairly large hospital operators — like CHI Dignity, Advocate Aurora here in the Midwest. But the hospital sector is a little more consolidated.

    On the non-hospital side — think of home health and hospice operators — those are highly fragmented markets, so even the largest operators in the space own less than 5% national market share.

    So there is a much larger opportunity there, and we expect names like Amedisys (NASDAQ:$AMED), LHC Group (NASDAQ:$LHCG) and Encompass Health (NYSE:$EHC) to find smaller tuck-in assets that they can add to fill in their national footprint where it makes sense.”

    The demographic trends are clear:
    Matt Larew is an Analyst who joined William Blair & Company, L.L.C. in September 2012 and primarily focuses on health care delivery companies. In 2018, Institutional Investor named Mr. Larew a Rising Star for the All-America Research Team. Before rec
    Matt Larew is an Analyst who joined William Blair & Company, L.L.C. in September 2012 and primarily focuses on health care delivery companies. In 2018, Institutional Investor named Mr. Larew a Rising Star for the All-America Research Team. Before rec
    www.twst.com